Infectious diseases pose a threat to national security, but also have an economic value through the pathogen sharing practices, which aim to prevent, or at least strenghten capacities of reaction in case of crises. The Ebola crisis proved how critical pathogen sharing is to controlling outbreaks and thus, how beneficial sharing can be. However, existing governing frameworks for this process have several shortcomings, are under strain, and are very complicated. Furthermore, there are emergent technologies that take away the incentives to share.
The research questions guiding the analysis are as follows:
The methodology envisaged to answer them includes both quantitative and qualitative analysis. Metrics will be developed for pathogen-sharing and they will be submitted to specialized focus groups for discussions and analysis. Two case studies of Ebola and Zika will be analyzed in depth. Hypotheses for policy will be developed and tested.
Access to pathogens and the sharing of benefits arising from their use is a key concern for global health. Across recent outbreaks, including Ebola, Zika, MERS-CoV, and the newly emergent SARS-CoV-2, questions around the sharing of samples and related genomic sequencing data (GSD) and their associated benefits have been central considerations. Given a growing recognition of the need to ensure timely and fair pathogen- and benefit-sharing (PBS)1 for pathogens of pandemic potential among humans, a 4-hour online workshop, Governing Pathogen- and Benefit-Sharing: From pandemic influenza to other pathogens of pandemic potential, was held on July 2, 2020. In advance of the meeting, the organizers2 prepared a draft research report on drivers and challenges for PBS and the breadth and scope of policy options proposed for PBS governance.
Though ensuring the fair, reliable, and rapid international sharing of pathogen samples and related benefits is necessary to control infectious disease outbreaks, it has proven difficult. We gathered data from two country cases, influenza sample movements, interviews, and contracts to understand current practices and perceptions. We found that countries shared pathogens for instrumental, political, security, economic and scientific reasons; and that benefits were sought for the global public interest, academic recognition, strengthening national capacities, and economic returns. During outbreaks, barriers arose due to disparities in technology and capacity, biosecurity concerns, commercial interests, and the absence of clear rules. We found consensus on the urgency of improving the global governance of PBS, but not on how to do so. We discuss the options proposed for PBS governance and the need for more focused political leadership to achieve global health security, with equity.
Suerie Moon
Coordinator
The Graduate Institute
Gian Luca Burci
Co-Coordinator
The Graduate Institute
Anthony Rizk
Principal Member
The Graduate Institute
Sylvie Briand
Associated Member
WHO
Anne Huvos
Associated Member
WHO
Rebecca Katz
Associated Member
Georgetown University
Mosoka Fallah
Associated Member
National Public Health Institute of Liberia
Jorge Bermudez
Associated Member
National School of Public Health at Fundação Oswaldo Cruz (Fiocruz), Brazil
Read about: “The Global Governance of Outbreaks: From Ebola to Coronavirus” by Suerie Moon
Swiss Network for
International Studies